1 |
Sambrook P, Cooper C. Osteoporosis. Lancet. 2006;367(9527):2010-8.
DOI
|
2 |
Korea Centers for Disease Control and Prevention. 2010 National Health Statistics and 2010 Health Behavior and Chronic Disease Statistics[cited October 18, 2018]. Available from:URL: https://knhanes.cdc.go.kr/knhanes/sub04/sub04_03.do.
|
3 |
National Osteoporosis Foundation. Clinician's guide prevention and treatment of osteoporosis. 2008.
|
4 |
International Osteoporosis Foundation. Who's at risk?[cited October 18, 2018]. Available from:URL:https://www.iofbonehealth.org/whos-risk.
|
5 |
The Society of Korean Medicine Obstetrics and Gynecology. Oriental Obstetrics & Gynecology 3rd edition. Seoul:Euiseongdang publisher. 2016:252-4.
|
6 |
World Health Organization. Prevention and Management of Osteoporosis. 2003.
|
7 |
Korean Society for Bone and Mineral Research. Physician's guide for diagnosis & treatment of osteoporosis. 2015.
|
8 |
Camacho PM, et al. American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis - 2016. Endocr Pract. 2016;22(4):1-42.
DOI
|
9 |
Gennari L, et al. Treatment needs and current options for postmenopausal osteoporosis. Expert Opin Pharmacother. 2016;17(8):1141-52.
DOI
|
10 |
Seo MS, et al. The Review on the Study of Osteoporosis in Korean Medicine Journals. The Journal of Korea CHUNA Manual Medicine for Spine & Nerves. 2013;8(2):67-78.
|
11 |
Kim JY, Song YS. The Study about the Comparison of Korean-Western Medicine on Osteoporosis. Journal of Oriental Rehabilitation Medicine. 1996;6:293-315.
|
12 |
Kim HG, Yu JY, Lee EJ. The study about the comparison of Korean- Western medicine on sin-ju-gol(腎主骨). The Journal of Korean Oriental Internal Medicine. 1991;12(2):26-9.
|
13 |
Lee CH, Lee IS. The Study of Document on Osteoporosis through Oriental Medicine. Dong-Eui Institute of Oriental Medicine. 2000 Dec;4:107-27.
|
14 |
National College of Oriental Medicine Common Textbook Compilation Committee. Herbal medicine(本草學). Seoul:Yeonglimsa. 2008:594-7.
|
15 |
Zhang H, et al. Antioxidant activity and physicochemical properties of an acidic polysaccharide from Morinda officinalis. Int J Biol Macromol. 2013;58:7-12.
DOI
|
16 |
Wat E, et al. The protective effect of Herba Cistanches on statin-induced myotoxicity in vitro. J Ethnopharmacol. 2016;190:68-73.
DOI
|
17 |
Heo J. Dongeuibogam. Seoul:Bubinbooks. 2008.
|
18 |
Nam SH, et al. Topically administered Risedronate shows powerful antiosteoporosis effect in ovariectomized mouse model. Bone. 2012;50(1):149-55.
DOI
|
19 |
Kang SJ, et al. Selection of the Optimal Herbal Compositions of Red Clover and Pomegranate according to their Protective Effect against Climacteric Symptoms in Ovariectomized Mice. Nutrients. 2016;8(8):447.
DOI
|
20 |
Harris ST, et al. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group. JAMA. 1999;282(14):1344-52.
DOI
|
21 |
Kang SJ, et al. Fermentation with Aquilariae Lignum enhances the antidiabetic activity of green tea in type II diabetic db/db mouse. Nutrients. 2014;6(9):3536-71.
DOI
|
22 |
Joo JH, et al. A Novel Pyrazole Derivative Protects from Ovariectomyinduced Osteoporosis through the Inhibition of NADPH oxidase. Sci Rep. 2016;6:22389.
DOI
|
23 |
Ludbrook J. Update: Microcomputer Statistics Packages. A personal view. Clin Exp Pharmacol Physiol. 1997;24(3-4):294-6.
DOI
|
24 |
Levene A. Pathological factors influencing excision of tumours in the head and neck. Part I. Clin Otolaryngol Allied Sci. 1981;6(2):145-51.
DOI
|
25 |
Choi JS, et al. Blood glycemiamodulating effects of melanian snail protein hydrolysates in mice with type II diabetes. Int J Mol Med. 2017;39(6):1437-51.
DOI
|
26 |
Manolagas SC, Kousteni S, Jilka RL. Sex steroids and bone. Recent Prog Horm Res. 2002;57:385-409.
DOI
|
27 |
Shin HD, et al. Antiosteoporotic effect of Polycan, beta-glucan from Aureobasidium, in ovariectomized osteoporotic mice. Nutrition. 2007;23(11-12):853-60.
DOI
|
28 |
Rodan GA, Martin TJ. Therapeutic Approaches to Bone Diseases. Science. 2000;289(5484):1508-14.
DOI
|
29 |
MacDonald BR, Gowen M. Emerging Therapies in Osteoporosis. Best Pract Res Clin Rheumatol. 2001;15(3):483-96.
DOI
|
30 |
Wu YB, et al. Antiosteoporotic Activity of Athraquinones from Morinda officinalis on Osteoblasts and Osteoclasts. Molecules. 2009;14(1):573-83.
DOI
|
31 |
Li TM, et al. Cistanche deserticola extract increases bone formation in osteoblasts. J Pharm Pharmacol. 2012;64(6):897-907.
DOI
|
32 |
Xu X, et al. Therapeutic Effect of Cistanoside A on bone metabolism of ovariectomized mice. Molecules. 2017;22(2):197.
DOI
|
33 |
Lorden JF, Caudle A. Behavioral and Endocrinological Effects of Single Injections of Monosodium Glutamate in the Mouse. Neurobehav Toxicol Teratol. 1986;8(5):509-19.
|
34 |
Kang SJ, et al. Dried pomegranate potentiates anti-osteoporotic and antiobesity activities of red clover dry extracts in ovariectomized rats. Nutrients. 2015;7(4):2622-47.
DOI
|
35 |
Choi JS, et al. Effect of Polycalcium, a mixture of Polycan and calcium lactate-gluconate in a 1:9 weight ratio, on rats with surgery-induced osteoarthritis. Exp Ther Med. 2015;9(5):1780-90.
DOI
|
36 |
Park SI, et al. The Effects of Topical Application of Polycal (a 2:98 (g/g) Mixture of Polycan and Calcium Gluconate) on Experimental Periodontitis and Alveolar Bone loss in Rats. Molecules. 2016;21(4):527.
DOI
|
37 |
Ke HZ, et al. Long-term treatment of lasofoxifene preserves bone mass and bone strength and dose not adversely affect the uterus in ovariectomized rats. Endocrinology. 2004;145(4):1996-2005.
DOI
|
38 |
Bain SD, et al. High-dose Estrogen Inhibits Bone Resorption and Stimulates Bone Formation in the Ovariectomized Mouse. J Bone Miner Res. 1993;8(4):435-42.
DOI
|
39 |
Andersson N et al. Repeated in vivo Determinations of Bone Mineral Density During Parathyroid Hormone Treatment in Ovariectomized Mice. J Endocrinol. 2001;170(3):529-37.
DOI
|
40 |
Yamamoto M, et al. The Integrin Ligand Echistatin Prevents Bone Loss in Ovariectomized Mice and Rats. Endocrinology. 1998;139(3):1411-9.
DOI
|
41 |
Ederveen AG, Kloosterboer HJ. Tibolone, a steroid with a tissue-specific hormonal profile, completely prevents ovariectomyinduced bone loss in sexually mature rats. J Bone Miner Res. 1999;14(11):1963-70.
DOI
|
42 |
Ismail F, et al. Serum bone gla protein and the vitamin D endocrine system in the oophorectomized rat. Endocrinology. 1988;122(2):624-30.
DOI
|
43 |
Park JH. Euiyuksinnongbonchokyung (意譯神農本草經). Seoul:Sinil seojeok. 2014:4-5.
|
44 |
Tanaka S, et al. Acute effects of ovariectomy on wound healing of alveolar bone after maxillary molar extraction in aged rats. Anat Rec. 2001;262(2):203-12.
DOI
|
45 |
Tarvainen R, et al. Clodronate Prevents Immobilization Osteopenia in Rats. Acta Orthop Scand. 1994;65(16):643-6.
DOI
|
46 |
Syed Z, Khan A. Bone Densitometry: applications and limitations. J Obstet Gynecol Can. 2002;24(6):476-84.
DOI
|
47 |
Diez F. Guidelines for the Diagnosis of Osteoporosis by Densitometric Methods. J Manipulative Physiol Ther. 2002;25(6):403-15.
DOI
|